Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade.
Meng HeZi-Fan ChenLi ZhangXiangyu GaoXiaoyi ChongHao-Shen LiLin ShenJia Fu JiXiaotian ZhangBin DongZi-Yu LiTang LeiPublished in: Journal for immunotherapy of cancer (2023)
Pretreatment SFA and SII were significantly associated with OS in patients with advanced gastric cancer. A comprehensive analysis of SII and SFA may improve the prognostic stratification of patients with gastric cancer receiving dual PD-1 and HER2 blockade.